ArticleJournal of biomedical physics & engineering2025
An Investigation of Dosimetric Consequences of the Anatomic Changes at First Fraction in VMAT of Prostate Cancer Cases using Deformable Planning CT and KVCBCT Image Registration.
Article in Journal of biomedical physics & engineering, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Comparison of deformable image registration algorithms for planning CT and CBCT in prostate cancer patients treated with external beam radiation therapy.Radiological physics and technology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Kilovoltage Cone Beam Computed Tomography (kVCBCT) is used for patient setup, monitoring the delivered dose, and adapting the treatment to changes in the patient's condition. Radiation therapy has recently shifted from image guidance to dose guidance, resulting in accurately calculating the daily dose, calculated by re-simulating CT-based treatment planning, to increase the precision of the actual treatment dosage. The use of kVCBCT instead of re-simulated CT can simplify the patient pathway and reduce potential therapeutic errors by eliminating the need for additional simulation. Objective: The present study aimed to assess the dosimetric effects of anatomical changes on prostate tumors using Deformation Image Registration (DIR) and kVCBCT. Material and Methods: In this experimental study, eight patients with primary prostate cancer were treated with Volumetric Modulated Arc Therapy (VMAT), and kVCBCT images were obtained for each patient during the first treatment fraction. Both the planning CT (pCT) and kVCBCT images were imported into DIR software. The pCT was then deformed to the kVCBCT image and imported into a Treatment Planning System (TPS). A new contour was created on the deformed Computed Tomography (dCT) using Atlas-based Auto-segmentation (ABAS). Daily dCT plans were individually created based on the same planning principles using the new contours and also denoted dCTp1 through dCTp8. The outcomes of dose calculations were compared using Dose Volume Histograms (DVH), including mean Planning Target Volume (PTV) doses at the prescribed dose and dose volume limitations for the bladder and rectal wall. Results: The mean doses to the PTV in the eight dCT-based plans were the same as those in the pCT-based plans. However, the mean doses to organs at risk in the dCT plans were different from those in the pCT plans. The mean doses to the bladder were on average 4% lower than those in the pCT plans, while the mean doses to the rectum were on average 8% higher than those in the pCT plans. Conclusion: The use of VMAT based on kilovoltage kVCBCT and Deformtion Image Registration (DIR) can lead to re-decreasing the dose to the bladder while increasing that to the rectum, with the same PTV dose coverage.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.